Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William B Mitchell, MD
Weill Medical College of Cornell University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Puerto Rico Hemophilia Treatment Center
San Juan, Puerto Rico
- City of Hope National Medical Center
Duarte, California, United States
- Mountain States Regional Hemophilia and Thrombosis Center
Aurora, Colorado, United States
- Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Emory University Hemophilia Program Office
Atlanta, Georgia, United States
- Northwestern University
Chicago, Illinois, United States
- University of Kentucky Hemophilia Treatment Center
Lexington, Kentucky, United States
- Boston Hemophilia Center- Children'S Hospital
Boston, Massachusetts, United States
- Henry Ford Hospital Adult Hemophilia and Thrombosis Treatment Center
Detroit, Michigan, United States
- Newark Beth Israel Medical Center
Newark, New Jersey, United States
- Hemophilia Center of Western New York - Pediatric
Buffalo, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- Weill Cornell Medical College
New York, New York, United States
- Mary M. Gooley Hemophilia Center, Inc.
Rochester, New York, United States
- Children'S Hospital Medical Center of Akron
Akron, Ohio, United States
- Cincinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Oklahoma Center for Bleeding Disorders
Oklahoma City, Oklahoma, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Gulf States Hemophilia and Thrombophilia Center
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2005
- Primary completion
- 31 Jan 2010
- Completion
- 31 Jan 2010
- Last update posted
- 10 Dec 2012
- Registered enrollment
- 22
- Registry id
- NCT00936845
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.